Mutated E-Cadherin: Genomic and Functional Characterization in Thyroid Cells from the KAT Family

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Thyroid

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/thy.2004.14.902PMID 15671768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell–cell adhesion and to suppress invasion

  2003cited by this paper
• E‐cadherin loss rather than β‐catenin alterations is a common feature of poorly differentiated thyroid carcinomas

  2003cited by this paper
• Clinical, cellular, and molecular aspects of cancer invasion.

  2003influential reference
• Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing.

  2003cited by this paper
• Genetic screening for hereditary diffuse gastric cancer

  2003cited by this paper
• High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

  2003cited by this paper
• BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

  2003cited by this paper
• Plasmin Produces an E-Cadherin Fragment That Stimulates Cancer Cell Invasion

  2002cited by this paper
• Follicular Growth of a Thyroid Carcinoma Cell Line (KAT-4) with Abnormal E-Cadherin and Impaired Epithelial Barrier

  2002influential reference
• Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Short tandem repeat profiling provides an international reference standard for human cell lines

  2001cited by this paper
• Alkyl‐lysophospholipid 1‐O‐octadecyl‐2‐O‐methyl‐ glycerophosphocholine induces invasion through episialin‐mediated neutralization of E‐cadherin in human mammary MCF‐7 cells in vitro

  2001cited by this paper
• Abnormalities of the E‐cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant

  2001cited by this paper
• The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression

  2001cited by this paper
• Defective E-cadherin/catenin complexes in human cancer

  2001cited by this paper
• Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis

  2000cited by this paper
• The expression of cadherins in human neuroblastoma cell lines and clinical tumors.

  2000cited by this paper
• Tumor-Derived Mutated E-Cadherin Influences β-Catenin Localization and Increases Susceptibility to Actin Cytoskeletal Changes Induced by Pervanadate

  2000cited by this paper
• The community effect in FGF-1 mediated tumor progression of a rat bladder carcinoma does not involve a direct paracrine signaling

  1999cited by this paper
• N‐cadherin‐mediated adhesion and aberrant catenin expression in anaplastic thyroid‐carcinoma cell lines

  1999cited by this paper
• Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility

  1999cited by this paper
• Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma.

  1998cited by this paper
• E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1

  1998cited by this paper
• Did the four human cancer cell lines DLD-1, HCT-15, HCT-8, and HRT-18 originate from one and the same patient?

  1998cited by this paper
• A causal role for E-cadherin in the transition from adenoma to carcinoma

  1998cited by this paper
• Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.

  1997cited by this paper
• E‐cadherin gene alterations are rare events in thyroid tumors

  1997cited by this paper
• The E-cadherin/catenin complex in invasion and metastasis.

  1996cited by this paper
• E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

  1996cited by this paper
• Congenital hypothyroidism caused by a premature termination signal in exon 10 of the human thyroid peroxidase gene.

  1996cited by this paper
• Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells.

  1995cited by this paper
• E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.

  1994cited by this paper
• In vivo and in vitro invasiveness of a rat colon‐cancer cell line maintaining E‐cadherin expression: An enhancing role of tumor‐associated myofibroblasts

  1994cited by this paper
• Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro.

  1993cited by this paper
• Epithelial‐mesenchymal transitions during cell culture of primary thyroid tumors?

  1993cited by this paper
• Molecular basis of epithelial tumorigenesis: the thyroid model.

  1993cited by this paper
• Cadherin cell adhesion receptors as a morphogenetic regulator.

  1991cited by this paper
• Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

  1991cited by this paper
• Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion

  1989cited by this paper

• E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.

  2016cites this paper
• "Thyroid cancer" cell line misidentification: a time for proactive change.

  2008cites this paper
• Regulation of 14-3-3sigma expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation.

  2008cites this paper
• Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

  2008cites this paper
• Molecular and Genotypic Characterization of Human Thyroid Follicular Cell Carcinoma–Derived Cell Lines

  2007cites this paper
• Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype.

  2007influential citation
• RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma

  2006cites this paper